Works matching IS 10880224 AND DT 2022 AND VI 28 AND IP 7


Results: 12
    1

    Projected US Savings From Biosimilars, 2021-2025.

    Published in:
    American Journal of Managed Care, 2022, v. 28, n. 7, p. 329, doi. 10.37765/ajmc.2022.88809
    By:
    • Mulcahy, Andrew;
    • Buttorff, Christine;
    • Finegold, Kenneth;
    • El-Kilani, Zeid;
    • Oliver, Jon F.;
    • Murphy, Stephen;
    • Jessup, Amber
    Publication type:
    Article
    2
    3
    4
    5

    Provider and Patient Insights Into the Cancer Care Journey.

    Published in:
    American Journal of Managed Care, 2022, v. 28, n. 7, p. 314, doi. 10.37765/ajmc.2022.89178
    By:
    • McLarty, Sarah;
    • Johnson II, Kjel A.;
    • Francis, E. Ann;
    • Johlie, Melissa;
    • Sawicki, Christine;
    • Avalos-Reyes, Elisea;
    • Johnson, Kjel A.
    Publication type:
    Article
    6
    7
    8
    9

    Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population.

    Published in:
    American Journal of Managed Care, 2022, v. 28, n. 7, p. 349, doi. 10.37765/ajmc.2022.89181
    By:
    • Gabot, Alan;
    • Lavitas, Pavel;
    • Bacon, Rachel;
    • Pomfret, Thomas C.;
    • Taylor, Mckenzie;
    • Coelho, Andrew;
    • Greenwood, Bonnie C.;
    • Alper, Caroline J.;
    • Clements, Karen M.;
    • Lenz, Kimberly
    Publication type:
    Article
    10
    11
    12